• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青霉胺和锌对肝豆状核变性患者铁代谢的影响。

Effect of penicillamine and zinc on iron metabolism in Wilson's disease.

作者信息

Medici Valentina, Di Leo Vincenza, Lamboglia Francesca, Bowlus Christopher L, Tseng Szu-Ching, D'Incà Renata, Irato Paola, Burra Patrizia, Martines Diego, Sturniolo Giacomo C

机构信息

Department of Surgical and Gastroenterological Sciences, Section of Gastroenterology, University of Padua, Padua, Italy.

出版信息

Scand J Gastroenterol. 2007 Dec;42(12):1495-500. doi: 10.1080/00365520701514495.

DOI:10.1080/00365520701514495
PMID:17994470
Abstract

OBJECTIVE

The physiology of iron metabolism in Wilson's disease is largely unknown, and there is a paucity of data on the real presence and progression of iron accumulation. The purpose of this study was to assess the iron metabolism parameters, including hepatic iron concentration, in follow-up liver biopsies and serum, and urinary pro-hepcidin.

MATERIAL AND METHODS

Twenty-three Wilson's disease patients undergoing long-term treatment were enrolled in the study.

RESULTS

Hepatic iron content was significantly increased in penicillamine-treated patients compared with zinc-treated patients. Serum and urinary pro-hepcidin concentrations were significantly higher in Wilson's disease patients than in healthy volunteers, despite a normal biochemical pattern of iron metabolism.

CONCLUSIONS

Long-term penicillamine treatment seems to be responsible for a more marked iron accumulation in the liver. This observation may justify a revision of long-term Wilson's disease treatment modalities with penicillamine. The finding that serum and urinary pro-hepcidin is significantly increased in Wilson's disease patients compared with healthy volunteers suggests a role for hepcidin in iron metabolism in Wilson's disease, but this needs to be confirmed by a study of hepatic hepcidin expression in these patients.

摘要

目的

肝豆状核变性中铁代谢的生理学机制在很大程度上尚不清楚,关于铁蓄积的实际存在情况和进展的数据也很匮乏。本研究的目的是评估随访肝活检、血清和尿前铁调素中的铁代谢参数,包括肝脏铁浓度。

材料与方法

本研究纳入了23例接受长期治疗的肝豆状核变性患者。

结果

与接受锌治疗的患者相比,接受青霉胺治疗的患者肝脏铁含量显著增加。尽管铁代谢的生化模式正常,但肝豆状核变性患者的血清和尿前铁调素浓度显著高于健康志愿者。

结论

长期青霉胺治疗似乎导致肝脏中铁蓄积更为明显。这一观察结果可能为修订肝豆状核变性长期使用青霉胺的治疗方式提供依据。与健康志愿者相比,肝豆状核变性患者血清和尿前铁调素显著升高这一发现表明铁调素在肝豆状核变性铁代谢中起作用,但这需要通过对这些患者肝脏铁调素表达的研究来证实。

相似文献

1
Effect of penicillamine and zinc on iron metabolism in Wilson's disease.青霉胺和锌对肝豆状核变性患者铁代谢的影响。
Scand J Gastroenterol. 2007 Dec;42(12):1495-500. doi: 10.1080/00365520701514495.
2
Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.锌疗法可提高威尔逊氏病患者十二指肠中金属硫蛋白和铁的浓度。
Am J Gastroenterol. 1999 Feb;94(2):334-8. doi: 10.1111/j.1572-0241.1999.851_w.x.
3
Iron accumulation in the liver of male patients with Wilson's disease.威尔逊氏病男性患者肝脏中的铁蓄积。
Am J Gastroenterol. 2001 Nov;96(11):3147-51. doi: 10.1111/j.1572-0241.2001.05269.x.
4
Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.锌治疗可预防威尔逊病中的脂质过氧化并增加谷胱甘肽的可用性。
J Lab Clin Med. 2003 Jun;141(6):372-7. doi: 10.1016/S0022-2143(03)00027-1.
5
Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.在没有替代孤儿药(曲恩汀 - 锌)的情况下停用青霉胺:1例威尔逊病失代偿期肝硬化病例
J Clin Pharm Ther. 2007 Feb;32(1):101-7. doi: 10.1111/j.1365-2710.2007.00794.x.
6
Diagnosis and management of Wilson's disease: results of a single center experience.威尔逊病的诊断与管理:单中心经验结果
J Clin Gastroenterol. 2006 Nov-Dec;40(10):936-41. doi: 10.1097/01.mcg.0000225670.91722.59.
7
Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.在威尔逊病中从硫酸锌-青霉胺维持治疗中停用青霉胺:有前景、安全且廉价。
J Neurol Sci. 2008 Jan 15;264(1-2):129-32. doi: 10.1016/j.jns.2007.08.006. Epub 2007 Sep 4.
8
Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.青霉胺诱发威尔逊病患儿及威尔逊病母亲所生健康婴儿的甲状腺功能减退和激素合成障碍。
J Pediatr. 2008 Dec;153(6):864-6. doi: 10.1016/j.jpeds.2008.06.015.
9
Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.儿童威尔逊病的综合征变异性。44例临床研究。
Ital J Gastroenterol Hepatol. 1997 Apr;29(2):155-61.
10
Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.肝移植:威尔逊病肝脏和神经表现的首选治疗方法。
Clin Transplant. 1997 Jun;11(3):217-24.

引用本文的文献

1
The Role of Glia in Wilson's Disease: Clinical, Neuroimaging, Neuropathological and Molecular Perspectives.《肝豆状核变性中神经胶质细胞的作用:临床、神经影像学、神经病理学和分子学视角》。
Int J Mol Sci. 2024 Jul 9;25(14):7545. doi: 10.3390/ijms25147545.
2
Gandouling Mitigates CuSO-Induced Heart Injury in Rats.甘豆灵减轻硫酸铜诱导的大鼠心脏损伤。
Animals (Basel). 2022 Oct 8;12(19):2703. doi: 10.3390/ani12192703.
3
Hepatocellular Carcinoma: An Unusual Complication of Longstanding Wilson Disease.肝细胞癌:长期威尔逊病的一种罕见并发症。
J Clin Exp Hepatol. 2017 Jun;7(2):152-154. doi: 10.1016/j.jceh.2016.09.012. Epub 2016 Sep 21.
4
Wilson's disease: A review of what we have learned.威尔逊氏病:我们所了解内容的综述。
World J Hepatol. 2015 Dec 18;7(29):2859-70. doi: 10.4254/wjh.v7.i29.2859.
5
Hepatocellular carcinoma in a non-cirrhotic patient with Wilson's disease.非肝硬化Wilson 病患者的肝细胞癌。
World J Gastroenterol. 2013 Apr 7;19(13):2110-3. doi: 10.3748/wjg.v19.i13.2110.
6
Brain proton magnetic spectroscopy in long-term treatment of Wilson's disease patients.脑质子磁共振波谱在肝豆状核变性患者长期治疗中的应用。
Metab Brain Dis. 2010 Sep;25(3):325-9. doi: 10.1007/s11011-010-9214-x. Epub 2010 Sep 14.